LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.
Kumaraswamy A, Duan Z, Flores D, Zhang C, Sehrawat A, Hu YM, Swaim OA, Rodansky E, Storck WK, Kuleape JA, Bedi K, Mannan R, Wang XM, Udager A, Ravikumar V, Bankhead A 3rd, Coleman I, Lee JK, Morrissey C, Nelson PS, Chinnaiyan AM, Rao A, Xia Z, Yates JA, Alumkal JJ.
Kumaraswamy A, et al. Among authors: udager a.
JCI Insight. 2023 Aug 8;8(15):e167440. doi: 10.1172/jci.insight.167440.
JCI Insight. 2023.
PMID: 37440313
Free PMC article.